Table 1. A comparison of the baseline characteristics between the LTC and non-LTC groups.
| LTC (n = 710) | non-LTC (n = 5,045) | p-values | ||
|---|---|---|---|---|
| Sex (%) | Males | 34.8 | 38.9 | 0.033* |
| Age (years) | 74.8 ± 5.0 | 70.8 ± 4.3 | <0.001* | |
| Clinical data | BMI (kg/m2) | 23.9 ± 3.5 | 24.1 ± 3.2 | 0.225 |
| SBP (mmHg) | 132.6 ± 18.8 | 131.2 ± 19.6 | 0.083 | |
| DBP (mmHg) | 74.8 ± 10.1 | 75.5 ± 10.5 | 0.055 | |
| TC (mg/dl) | 199.2 ± 32.1 | 200.7 ± 31.7 | 0.228 | |
| HDLC (mg/dl) | 58.8 ± 14.3 | 58.7 ± 14.9 | 0.950 | |
| Non-HDLC (mg/dl) | 140.4 ± 32.0 | 142.0 ± 31.3 | 0.212 | |
| Hb (g/dl) | 13.3 ± 1.4 | 13.5 ± 1.3 | <0.001* | |
| HbA1c (%) | 5.2 ± 0.8 | 5.6 ± 0.7 | 0.166 | |
| eGFR (mL/min/1.73 m2) | 68.3 ± 10.7 | 71.9 ± 8.5 | <0.001* | |
| Educational years (%) | < 7 years | 36.6 | 21.4 | <0.001* |
| Current smoker (%) | 10.8 | 9.8 | 0.379 | |
| Current drinker (%) | 25.4 | 31.3 | 0.001* | |
| Hypertension (%) | 60.7 | 52.6 | <0.001* | |
| Diabetes mellitus (%) | 18.5 | 12.4 | <0.001* | |
| Dyslipidemia (%) | 34.1 | 37.5 | 0.074 | |
| Atrial fibrillation (%) | 3.9 | 1.8 | <0.001* | |
| Interim CVD | Overall (%) | 17.9 | 3.2 | <0.001* |
| Stroke (%) | 14.9 | 2.3 | ||
| MI (%) | 0.5 | 0.4 | ||
| HF (%) | 1.6 | 0.6 | ||
| Stroke and MI (%) | 0.0 | 0.1 | ||
| Stroke and HF (%) | 0.3 | 0.0 | ||
| HF and MI (%) | 0.3 | 0.1 | ||
| Biomarkers (median, IQR) | ||||
| UACR (mg/g Cr) | 21.8 (11.1–49.7) | 15.8 (6.1–32.9) | <0.001* | |
| BNP (pg/ml) | 28.4 (15.3–54.4) | 22.8 (12.3–39.9) | <0.001* | |
| hsCRP (mg/l) | 0.5 (0.3–1.1) | 0.5 (0.3–1.0) | 0.403 |
LTC, long-term care; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; HDLC, high-density lipoprotein cholesterol; non-HDLC, non-high-density lipoprotein cholesterol; Hb, blood hemoglobin; HbA1c, glycosylated hemoglobin; eGFR, estimated glomerular filtration rate; CVD, cardiovascular disease; Cr, creatinine; MI, myocardial infarction; HF, heart failure; UACR, urinary albumin-creatinine ratio; BNP, B-type natriuretic peptide; hsCRP, high-sensitivity C-reactive protein.
*Statistically significant